Rob Lawrence

Company: Immunome Inc.

Job title: Director, Biology

Seminars:

Panel Discussion: Curating a Target Selection Strategy With Adequate Risk Management to Maintain Investor Buy-In & Strategic Differentiation 9:30 am

Strategizing how to penetrate the dense ADC field whilst taking adequate risks in relation to target selection or ADC design Understanding the degree of risk deemed acceptable by prospective investors to decide the target of choice Considering scenarios appropriate to advance a novel ADC with a novel task, in a high risk approachRead more

day: Conference Day Two

Reviewing the Historical Developments of ADC Target Selection & Outlining an Update on the Current Clinical Progress Across Novel Targets 9:45 am

Collating the historical evidence of ADC target selection to appreciate the origin of the field and the foundations that were built on Pinpointing the evolution of the field to date to understand the direction that we are moving in Sharing current clinical data to analyze the diversity of ADC targets that have advanced to a…Read more

day: Conference Day One

Food for Artificial Thought: What are We Feeding Our Artificial Intelligence Engines? 12:45 pm

Collaborating as a community of biologists, chemists and computational scientists to highlight the strengths and limitations of implementing AI into your ADC target selection strategy Listing the required level of depth of data input needed to elicit the desired response from AI engines Adopting a premium hybrid strategy: what sections of the target selection process…Read more

day: Conference Day One